Stryker Total Assets 2010-2025 | SYK

Stryker total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending March 31, 2025 were $46.006B, a 16.76% increase year-over-year.
  • Stryker total assets for 2024 were $42.971B, a 7.66% increase from 2023.
  • Stryker total assets for 2023 were $39.912B, a 8.21% increase from 2022.
  • Stryker total assets for 2022 were $36.884B, a 6.51% increase from 2021.
Stryker Annual Total Assets
(Millions of US $)
2024 $42,971
2023 $39,912
2022 $36,884
2021 $34,631
2020 $34,330
2019 $30,167
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
Stryker Quarterly Total Assets
(Millions of US $)
2025-03-31 $46,006
2024-12-31 $42,971
2024-09-30 $43,833
2024-06-30 $39,130
2024-03-31 $39,402
2023-12-31 $39,912
2023-09-30 $38,042
2023-06-30 $37,409
2023-03-31 $36,830
2022-12-31 $36,884
2022-09-30 $35,983
2022-06-30 $36,032
2022-03-31 $36,137
2021-12-31 $34,631
2021-09-30 $34,145
2021-06-30 $33,698
2021-03-31 $33,455
2020-12-31 $34,330
2020-09-30 $32,286
2020-06-30 $31,483
2020-03-31 $29,440
2019-12-31 $30,167
2019-09-30 $26,659
2019-06-30 $26,354
2019-03-31 $25,937
2018-12-31 $27,229
2018-09-30 $22,084
2018-06-30 $21,570
2018-03-31 $22,133
2017-12-31 $22,197
2017-09-30 $21,485
2017-06-30 $21,292
2017-03-31 $20,517
2016-12-31 $20,435
2016-09-30 $20,187
2016-06-30 $20,520
2016-03-31 $19,668
2015-12-31 $16,223
2015-09-30 $15,917
2015-06-30 $16,819
2015-03-31 $16,580
2014-12-31 $17,279
2014-09-30 $17,515
2014-06-30 $17,229
2014-03-31 $16,159
2013-12-31 $15,743
2013-09-30 $14,883
2013-06-30 $14,382
2013-03-31 $14,089
2012-12-31 $13,206
2012-09-30 $12,777
2012-06-30 $12,262
2012-03-31 $12,459
2011-12-31 $12,146
2011-09-30 $12,083
2011-06-30 $11,596
2011-03-31 $11,231
2010-12-31 $10,895
2010-09-30 $10,772
2010-06-30 $10,060
2010-03-31 $10,098
2009-12-31 $9,071
2009-09-30 $8,459
2009-06-30 $7,924
2009-03-31 $7,585
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $145.454B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00